Save
Busy. Please wait.
Log in with Clever
or
show password
Forgot Password?
Don't have an account?  Sign up 
Sign up using Clever
or
Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account. Your email address is only used to allow you to reset your password. See our Privacy Policy and Terms of Service.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.
focusNode
Didn't know it?
click below
 
Knew it?
click below
Don't Know
Remaining cards (0)
Know
0:00
edit
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how

ASFA guidelines

TQs

QuestionAnswer
Inflammatory demyelinating disorder characterized by attacks within spinal cord and optic nerve. Symptoms of myelitis include paraparesis and sensory loss below the lesion, sphincter loss, dyesthesia, and radicular pain. Neuromyelitis optica spectrum disorders (NMOSD), previously neuromyelitis optica (NMO) and Devic’s disease
ASFA category of NMO Category II
autoantibody against _______________ is pathogenic in NMOSD. aquaporin-4 (AQP4; NMO-IgG), the principal water channel on astrocyte foot processes at blood brain barrier, is pathogenic in NMOSD
Current diagnostic criteria for Neuromyelitis optica are: optic neuritis, acute myelitis, and at least two of three supportive criteria: contiguous spinal cord MRI lesions extending over 3 vertebral segments, brain MRI not meeting diagnostic criteria for MS, and NMO-seropositive status.
Acute attacks of NMO are managed by: high-dose intravenous steroids (usually intravenous pulse steroids (methylprednisone 1 g daily 3 5 days followed by oral steroid taper) and, if symptoms fail to resolve, TPE is added.
If a clinician asks you to do apheresis, you should examine the evidence
ASFA Category for disorders for which apheresis is accepted as first-line therapy, either as a primary standalone treatment or in conjunction with other modes of treatment. ASFA Category 1
ASFA Category for disorders for which apheresis is accepted as second-line therapy, either as a standalone treatment or in conjunction with other modes of treatment. ASFA Category II
ASFA Category for when the optimum role of apheresis therapy is not established. Decision making should be individualized. ASFA Category III
ASFA Category for Disorders in which published evidence demonstrates or suggests apheresis to be ineffective or harmful. IRB approval is desirable if apheresis treatment is undertaken in these circumstances. ASFA Category IV
The only Category I indication in the treatment of acute complications of sickle cell disease stroke
Created by: jfshikle
Popular Laboratory Science sets

 

 



Voices

Use these flashcards to help memorize information. Look at the large card and try to recall what is on the other side. Then click the card to flip it. If you knew the answer, click the green Know box. Otherwise, click the red Don't know box.

When you've placed seven or more cards in the Don't know box, click "retry" to try those cards again.

If you've accidentally put the card in the wrong box, just click on the card to take it out of the box.

You can also use your keyboard to move the cards as follows:

If you are logged in to your account, this website will remember which cards you know and don't know so that they are in the same box the next time you log in.

When you need a break, try one of the other activities listed below the flashcards like Matching, Snowman, or Hungry Bug. Although it may feel like you're playing a game, your brain is still making more connections with the information to help you out.

To see how well you know the information, try the Quiz or Test activity.

Pass complete!
"Know" box contains:
Time elapsed:
Retries:
restart all cards